The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes
Open accessAbstract
Statins, the widely prescribed cholesterol-lowering drugs for the treatment of cardiovascular disease, cause adverse skeletal muscle side effects ranging from fatigue to fatal rhabdomyolysis. The purpose of this study was to determine the effects of simvastatin on mitochondrial respiration, oxidative stress, and cell death in differentiated primary human skeletal muscle cells (i.e., myotubes). Simvastatin induced a dose-dependent decrease in viability of proliferating and differentiating primary human muscle precursor cells, and a similar dose-dependent effect was noted in differentiated myoblasts and myotubes. Additionally, there were decreases in myotube number and size following 48 h of simvastatin treatment (5 μM). In permeabilized myotubes, maximal ADP-stimulated oxygen consumption, supported by palmitoylcarnitine+malate (PCM, complex I and II substrates) and glutamate+malate (GM, complex I substrates), was 32-37% lower (P<0.05) in simvastatin-treated (5 μM) vs control myotubes, providing evidence of impaired respiration at complex I. Mitochondrial superoxide and hydrogen peroxide generation were significantly greater in the simvastatin-treated human skeletal myotube cultures compared to control. In addition, simvastatin markedly increased protein levels of Bax (proapoptotic, +53%) and Bcl-2 (antiapoptotic, +100%, P<0.05), mitochondrial PTP opening (+44%, P<0.05), and TUNEL-positive nuclei in human skeletal myotubes, demonstrating up-regulation of mitochondrial-mediated myonuclear apoptotic mechanisms. These data demonstrate that simvastatin induces myotube atrophy and cell loss associated with impaired ADP-stimulated maximal mitochondrial respiratory capacity, mitochondrial oxidative stress, and apoptosis in primary human skeletal myotubes, suggesting that mitochondrial dysfunction may underlie human statin-induced myopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently Kwak et al. (40) reported impaired ADP-stimulated respiration in primary human skeletal myotubes after 48 h of simvastatin treatment, and this was accompanied by increased mitochondrial oxidative stress (hydrogen peroxide emission).”
From Simvastatin Effects on Skeletal Muscle (2013) · cites this paper as [40]
In the citing paper
“Our findings of significantly reduced antioxidant capacity in combination with the known (3,40) elevated ROS production in the simvastatin-treated patients make it plausible that increased apoptosis could contribute to muscle pain in patients treated with statins.”
From Simvastatin Effects on Skeletal Muscle (2013) · cites this paper as [40]
In the citing paper
“In turn, an increased Ca 2ϩ load in the mitochondrial matrix has been linked to increased ROS production and increased permeability transition pore opening, leading to apoptosis (40,45).”
From Simvastatin Effects on Skeletal Muscle (2013) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R., Joyal, S. V., Hill, K. A., Pfeffer, M. A., & Skene, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040583 · Cited by 4,938
Wang, H., & Joseph, J. A. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00107-0 · Cited by 2,355
Thompson, P. D., Clarkson, P., & Karas, R. H. (2003) · JAMA · doi:10.1001/jama.289.13.1681 · Cited by 1,463
Anderson, E. J., Lustig, M. E., Boyle, K. E., Woodlief, T. L., Kane, D. A., Lin, C.-T., Price, J. W., Kang, L., Rabinovitch, P. S., Szeto, H. H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37048 · Cited by 1,253
Self-citationSafety of Statins: Focus on Clinical Pharmacokinetics and Drug Interactions
Bellosta, S., Paoletti, R., & Corsini, A. (2004) · Circulation · doi:10.1161/01.cir.0000131519.15067.1f · Cited by 578
Statin-associated myopathy with normal creatine kinase levels
Phillips, P. S., Haas, R. H., Bannykh, S., Hathaway, S., Gray, N. L., Kimura, B. J., Vladutiu, G. D., England, J. D. F., & and the Scripps Mercy Clinical Research Center* (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-7-200210010-00009 · Cited by 565
The Role of Coenzyme Q10 in Statin-Associated Myopathy
Marcoff, L., & Thompson, P. D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.049 · Cited by 537
Suction applied to a muscle biopsy maximizes sample size
Evans, W. J., Phinney, S. D., & Young, V. R. (1982) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-198201000-00018 · Cited by 525
Cited by
Sorted by citations
Banach, M., Rizzo, M., Toth, P. P., Farnier, M., Davidson, M. H., Al‐Rasadi, K., Aronow, W. S., Athyros, V. G., Djuric, D. M., Владиславович, Е. М., et al. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.49807 · Cited by 386
Effects of statins on mitochondrial pathways
Mollazadeh, H., Tavana, E., Fanni, G., Bo, S., Banach, M., Pirro, M., von Haehling, S., Jamialahmadi, T., & Sahebkar, A. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12654 · Cited by 270
Simvastatin Impairs Exercise Training Adaptations
Mikus, C. R., Boyle, L. J., Borengasser, S. J., Oberlin, D. J., Naples, S. P., Fletcher, J. A., Meers, G. M.-E., Ruebel, M. L., Laughlin, M. H., Dellsperger, K. C., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.074 · Cited by 249
Makrecka‐Kuka, M., Krumschnabel, G., & Gnaiger, E. (2015) · Biomolecules · doi:10.3390/biom5031319 · Cited by 237
Turner, R. M., & Pirmohamed, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010022 · Cited by 206
Mitophagy Is Required for Acute Cardioprotection by Simvastatin
Andres, A. M., Hernandez, G., Lee, P., Huang, C., Ratliff, E. P., Sin, J., Thornton, C. A., Damasco, M. V., & Gottlieb, R. A. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5416 · Cited by 189
Statins: Adverse reactions, oxidative stress and metabolic interactions
Liu, A., Wu, Q., Guo, J., Arés, I., Rodríguez, J.-L., Martínez‐Larrañaga, M., Yuan, Z., Anadón, A., Wang, X., & Martínez, M. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.10.004 · Cited by 168
Simvastatin Effects on Skeletal Muscle
Larsen, S., Stride, N., Hey-Mogensen, M., Hansen, C. N., Bang, L. E., Bundgaard, H., Nielsen, L. B., Helge, J. W., & Dela, F. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.036 · Cited by 165
Banach, M., Rizzo, M., Toth, P. P., Farnier, M., Davidson, M. H., Al-Rasadi, K., Aronow, W. S., Athyros, V., Djuric, D. M., Ezhov, M. V., et al. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1039980 · Cited by 162
Myotoxicity of statins: Mechanism of action
du Souich, P., Roederer, G. O., & Dufour, R. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.029 · Cited by 168
Mechanisms of statin-associated skeletal muscle-associated symptoms
Bouitbir, J., Sanvee, G. M., Panajatovic, M. V., Singh, F., & Krähenbühl, S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.03.010 · Cited by 152
The role of mitochondria in statin‐induced myopathy
Apostolopoulou, M., Corsini, A., & Roden, M. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12461 · Cited by 142
Gouni‐Berthold, I., Berthold, H. K., Huh, J. Y., Berman, R., Spenrath, N., Krone, W., & Mantzoros, C. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072858 · Cited by 134
Heightened muscle inflammation susceptibility may impair regenerative capacity in aging humans
Merritt, E. K., Stec, M. J., Thalacker-Mercer, A., Windham, S. T., Cross, J. M., Shelley, D. P., Craig Tuggle, S., Kosek, D. J., Kim, J.-S., & Bamman, M. M. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00019.2013 · Cited by 127
Self-citationBurguillos, M. Á., Magnusson, C., Antfolk, M., Lenshof, A., Augustsson, P., Hansson, M. J., Elmér, E., Lilja, H. G., Brundin, P., Laurell, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064233 · Cited by 122
Mechanisms and assessment of statin‐related muscular adverse effects
Moßhammer, D., Schaeffeler, E., Schwab, M. G., & Mörike, K. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12360 · Cited by 112
The AKT/mTOR signaling pathway plays a key role in statin-induced myotoxicity
Bonifacio, A., Sanvee, G. M., Bouitbir, J., & Krähenbühl, S. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.04.010 · Cited by 93
Bouitbir, J., Singh, F., Charles, A., Schlagowski, A.-I., Bonifacio, A., Echaniz‐Laguna, A., Gény, B., Krähenbühl, S., & Zoll, J. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6190 · Cited by 100
Muscle mitochondrial metabolism and calcium signaling impairment in patients treated with statins
Sirvent, P., Fabre, O., Bordenave, S., Hillaire-Buys, D., Raynaud De Mauverger, E., Lacampagne, A., & Mercier, J. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.01.008 · Cited by 90
Statins, Bcl-2, and Apoptosis: Cell Death or Cell Protection?
Wood, W. G., Igbavboa, U., Muller, W. E., & Eckert, G. P. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8496-5 · Cited by 92
Muntean, D. M., Thompson, P. D., Catapano, A. L., Stasiolek, M., Fabis, J., Muntner, P., Serban, M.-C., & Banach, M. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.09.001 · Cited by 82
Mitochondrial Respiratory Capacity and Content Are Normal in Young Insulin-Resistant Obese Humans
Fisher-Wellman, K. H., Weber, T. M., Cathey, B. L., Brophy, P. M., Gilliam, L. A. A., Kane, C. L., Maples, J. M., Gavin, T. P., Houmard, J. A., & Neufer, P. D. (2014) · Diabetes · doi:10.2337/db13-0940 · Cited by 82
Self-citationDastkhoon, M., Ghaedi, M., Asfaram, A., Arabi, M., Ostovan, A., & Goudarzi, A. (2016) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2016.10.030 · Cited by 79
Urbano, F., Bugliani, M., Filippello, A., Scamporrino, A., Mauro, S. D., Pino, A. D., Scicali, R., Noto, D., Rabuazzo, A. M., Averna, M. R., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11070-x · Cited by 79
Risk of diabetes in patients treated with HMG-CoA reductase inhibitors
Cho, Y., Choe, E.-Y., Lee, Y., Seo, J. W., Choi, Y., Yun, Y., Wang, H. J., Ahn, C. W., Soo, B., Lee, H. C., et al. (2014) · Metabolism · doi:10.1016/j.metabol.2014.09.008 · Cited by 73
Bonifacio, A., Mullen, P. J., Mityko, I. S., Navegantes, L. C. C., Bouitbir, J., & Krähenbühl, S. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1378-4 · Cited by 61
Marcheggiani, F., Cirilli, I., Orlando, P., Silvestri, S., Vogelsang, A., Knott, A., Blatt, T., Weise, J. M., & Tiano, L. (2019) · Aging · doi:10.18632/aging.101926 · Cited by 53
Egom, E. E. A., & Hafeez, H. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2015.10.005 · Cited by 57
Li, W., Liang, X., Zeng, Z., Yu, K., Zhan, S., Su, Q., Yan, Y., Mansai, H., Qiao, W., Yang, Q., et al. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.06.029 · Cited by 52
Guardia, P. G. L., Alberici, L. C., Ravagnani, F. G., Catharino, R. R., & Vercesi, A. E. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00103 · Cited by 46
Mechanisms of simvastatin myotoxicity: The role of autophagy flux inhibition
Emami, A., Shojaei, S., Rosa, S. C. D. S., Aghaei, M., Samiei, E., Vosoughi, A. R., Kalantari, F., Kawalec, P., Thliveris, J. A., Sharma, P. K., et al. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172616 · Cited by 42
Goldstein, M. R., & Mascitelli, L. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0368-x · Cited by 40
Mallinson, J. E., Constantin‐Teodosiu, D., Glaves, P. D., Martin, E. A., Davies, W. J., Westwood, F. R., Sidaway, J. E., & Greenhaff, P. L. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.238022 · Cited by 40
Southern, W. M., Nichenko, A. S., Shill, D. D., Spencer, C. C., Jenkins, N. T., McCully, K. K., & Call, J. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172551 · Cited by 39
Neuropsychological and physiological correlates of fatigue following traumatic brain injury
Zgaljardic, D. J., Durham, W. J., Mossberg, K. A., Foreman, J., Joshipura, K. D., Masel, B. E., Urban, R. J., & Sheffield‐Moore, M. (2014) · Brain Injury · doi:10.3109/02699052.2014.884242 · Cited by 41
Jiménez-Santos, M. A., Juárez‐Rojop, I. E., Tovilla‐Zárate, C. A., Espinosa-García, M. T., Juárez-Oropeza, M. A., Ramón-Frías, T., Bermudez‐Ocaña, D. Y., & Díaz-Zagoya, J. C. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-22 · Cited by 37
Costa, R. A. P. E., Fernandes, M. P., de Souza-Pinto, N. C., & Vercesi, A. E. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.001 · Cited by 35
Busanello, E. N. B., Marques, A. C. S., Lander, N. M., de Oliveira, D. N., Catharino, R. R., Oliveira, H. C. F., & Vercesi, A. E. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00185 · Cited by 34
The Impact of Exercise on Statin-Associated Skeletal Muscle Myopathy
Chung, H. R., Vakil, M., Munroe, M., Parikh, A., Meador, B. M., Wu, P. T., Jeong, J., Woods, J. A., Wilund, K. R., & Boppart, M. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168065 · Cited by 33
Barrat, E., Zaïr, Y., Sirvent, P., Chauveau, P., Maudet, C., Housez, B., Derbord, E., Lescuyer, J.-F., Bard, J.-M., Cazaubiel, M., et al. (2013) · European Journal of Nutrition · doi:10.1007/s00394-012-0486-2 · Cited by 31
The Influence of Statins on the Aerobic Metabolism of Endothelial Cells
Broniarek, I., Dominiak, K., Gałgański, Ł., & Jarmuszkiewicz, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041485 · Cited by 29
Huang, X., Liang, N. N., Fuming, Z., Lin, W., & Ma, W. (2024) · Antioxidants · doi:10.3390/antiox13060679 · Cited by 31
Simvastatin Inhibits Glucose Metabolism and Legumain Activity in Human Myotubes
Smith, R. L., Solberg, R., Jacobsen, L. L., Voreland, A. L., Rustan, A. C., Thoresen, G. H., & Johansen, H. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085721 · Cited by 29
Exercise-Pharmacology Interactions: Metformin, Statins, and Healthspan
Miller, B. F., & Thyfault, J. P. (2020) · Physiology · doi:10.1152/physiol.00013.2020 · Cited by 30
Jaśkiewicz, A., Pająk, B., Litwiniuk, A., Urbańska, K., & Orzechowski, A. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6463807 · Cited by 28
Use of antidepressants and statins and short-term risk of new-onset diabetes among high risk adults
Bhattacharya, R., Ajmera, M., Bhattacharjee, S., & Sambamoorthi, U. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.04.016 · Cited by 27
RYAN, T. E., Torres, M. J., Lin, C., Clark, A. H., Brophy, P. M., Smith, C. A., Smith, C. D., Morris, E. M., Thyfault, J. P., & Neufer, P. D. (2024) · JCI Insight · doi:10.1172/jci.insight.174125 · Cited by 27
Self-citationRen, L., Xuan, L., Han, F., Zhang, J., Gong, L., Lv, Y., Zhang, W., Yang, S. T., Xu, B., Yan, Y., et al. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115076 · Cited by 25
PGC-1β modulates statin-associated myotoxicity in mice
Singh, F., Zoll, J., Duthaler, U., Charles, A., Panajatovic, M. V., LAVERNY, G., McWilliams, T. G., METZGER, D., Gény, B., Krähenbühl, S., et al. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2369-7 · Cited by 23
Statin therapy, myopathy and exercise--a case report
Semple, S. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-40 · Cited by 22
Asping, M., Stride, N. O., Søgaard, D., Dohlmann, T. L., Helge, J. W., Dela, F., & Larsen, S. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2224-4 · Cited by 22
Kwak, H., Woodlief, T., Green, T. D., Cox, J. H., Hickner, R. C., Neufer, P. D., & Cortright, R. N. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16071157 · Cited by 23
Self-citationSkeletal muscle ultrastructure and function in statin-tolerant individuals
Rengo, J. L., Callahan, D. M., Savage, P. D., Ades, P. A., & Toth, M. J. (2015) · Muscle & Nerve · doi:10.1002/mus.24722 · Cited by 21
Cho, Y., Lee, M. J., Choe, E. Y., Jung, C. H., Joo, D. J., Kim, M. S., Soo, B., Park, J., & Kang, E. S. (2014) · Liver Transplantation · doi:10.1002/lt.23831 · Cited by 20
The Role of Mitochondria in Statin-Induced Myopathy
Bell, G. M., Thoma, A., Hargreaves, I. P., & Lightfoot, A. P. (2024) · Drug Safety · doi:10.1007/s40264-024-01413-9 · Cited by 21
Involvement of Monocarboxylate Transporter 4 Expression in Statin-Induced Cytotoxicity
Kikutani, Y., Kobayashi, M., Konishi, T., Sasaki, S., Narumi, K., Furugen, A., Takahashi, N., & Iseki, K. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.01.014 · Cited by 19
Zheng, P., Zhang, Q., Ma, W., Hu, R., Gu, Y., Bian, Z., Yang, D., Chen, X., & Wu, H. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176085 · Cited by 18
Marques, A. C. S., Busanello, E. N. B., de Oliveira, D. N., Catharino, R. R., Oliveira, H. C. F., & Vercesi, A. E. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00685 · Cited by 18
PGC‐1α plays a pivotal role in simvastatin‐induced exercise impairment in mice
Panajatovic, M. V., Singh, F., Roos, N. J., Duthaler, U., Handschin, C., Krähenbühl, S., & Bouitbir, J. (2019) · Acta Physiologica · doi:10.1111/apha.13402 · Cited by 17
Statin-induced Myopathy in Skeletal Muscle: the Role of Exercise
Kwak, H. (2014) · Journal of Lifestyle Medicine · doi:10.15280/jlm.2014.4.2.71 · Cited by 16
Self-citationAssis, L. H. D. P., Dorighello, G. G., Rentz, T., de Souza, J. C., Vercesi, A. E., & Oliveira, H. C. F. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.839428 · Cited by 15
A short-term statin treatment changes the contractile properties of fast-twitch skeletal muscles
Boulanger‐Piette, A., Dufresne, S. S., & Frenette, J. (2016) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-016-1306-2 · Cited by 15
Insulin prevents and reverts simvastatin-induced toxicity in C2C12 skeletal muscle cells
Sanvee, G. M., Bouitbir, J., & Krähenbühl, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-43938-5 · Cited by 14
Peric, D., Barragán, I., Giraud-Triboult, K., Egesipe, A.-L., Meyniel‐Schicklin, L., Cousin, C., Lotteau, V., Petit, V., Touhami, J., Battini, J., et al. (2015) · Stem Cells · doi:10.1002/stem.2107 · Cited by 14
Jaśkiewicz, A., Pająk, B., Łabieniec-Watała, M., Palma, C. D., & Orzechowski, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050694 · Cited by 13
Xue, Y., Tao, L., Wu, S., Wang, G., Lu, Q., Li, J., Liao, L., Tang, J.-F., & Ji, K. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0560-z · Cited by 12
Irwin, J. C., Fenning, A. S., Ryan, K., & Vella, R. K. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.09.040 · Cited by 12
Simvastatin profoundly impairs energy metabolism in primary human muscle cells
Mäkinen, S., Datta, N., Nguyen, Y. H., Kyrylenko, P., Laakso, M., & Koistinen, H. A. (2020) · Endocrine Connections · doi:10.1530/ec-20-0444 · Cited by 12
Modulation of Phospholipid Bilayer Properties by Simvastatin
Teo, R. D., & Tieleman, D. P. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c03359 · Cited by 12
Dayel, F. F. B., Alfirevic, A., & Chadwick, A. E. (2023) · Biomedicines · doi:10.3390/biomedicines11051485 · Cited by 11
Mahmoud, A. R., Kamel, E. O., Ahmed, M. A., Ahmed, E. A., & Abd‐Elhamid, T. H. (2019) · Cells Tissues Organs · doi:10.1159/000507048 · Cited by 11
Effect of L-carnitine on the skeletal muscle contractility in simvastatin-induced myopathy in rats
Ghalwash, M., Elmasry, A., & El-Adeeb, N. (2018) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2017-0156 · Cited by 10
Lorza‐Gil, E., García‐Arévalo, M., Favero‐Santos, B. C., Gomes‐Marcondes, M. C. C., & Oliveira, H. C. F. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2045-6 · Cited by 10
Cholesterol Management in Neurology: Time for Revised Strategies?
Andronie-Cioară, F. L., Jurcău, A., Jurcău, M. C., Nistor-Cseppento, C. D., & Simion, A. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12121981 · Cited by 9
Al-Shalchi, R. F., & MOHAMMAD, F. K. (2024) · Cureus · doi:10.7759/cureus.51433 · Cited by 7
Otrocka‐Domagała, I., Paździor‐Czapula, K., & Maślanka, T. (2018) · BioMed Research International · doi:10.1155/2018/7617312 · Cited by 7
Dynamic urine proteome changes in a rat model of simvastatin-induced skeletal muscle injury
Wei, J., Huan, Y., Heng, Z., Zhao, C., Jia, L., Yu, Y., & Gao, Y. (2022) · Journal of Proteomics · doi:10.1016/j.jprot.2021.104477 · Cited by 7
Murad, H. A. S. (2016) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1500065 · Cited by 6
d’Hose, D., Mignion, L., Hamelin, L., Sonveaux, P., Jordan, B. F., & Gallez, B. (2022) · Biomolecules · doi:10.3390/biom12101418 · Cited by 6
Effect of Statins on Superoxide Dismutase Level: A Systematic Review
Daliri, M., Simental‐Mendía, L. E., Jamialahmadi, T., Kesharwani, P., Reiner, Ž., & Sahebkar, A. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867331666230831145809 · Cited by 8
Corsetti, G., Pasini, E., Ferrari-Vivaldi, M., Romano, C., Bonomini, F., Tasca, G., Dioguardi, F. S., Rezzani, R., & Assanelli, D. (2012) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201202500423 · Cited by 6
Seo, D. Y., Heo, J., No, M., Yoo, S.-Z., Ko, J. R., Park, D., Kang, J., Kim, C., Jung, S., Han, J., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072292 · Cited by 6
Self-citationStatins, toxicity, and their adverse effects via oxidative imbalance
Anadón, A., Arés, I., Martínez-Larrañaga, M. R., & Martínez, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819092-0.00026-1 · Cited by 5
Somers, T., Siddiqi, S., Janssen, M. C. M., Morshuis, W. J., Maas, R. G. C., Buikema, J. W., van den Broek, P. H. H., Schirris, T. J. J., & Rüssel, F. G. M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117492 · Cited by 5
Jianfei, L., Wang, M., Ma, C.-L., Chen, B., Zhang, J., & Wang, B. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.10.005 · Cited by 5
Saied, S., Prokopidis, K., Adenaya, A., Isanejad, M., & Sankaranarayanan, R. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1293537 · Cited by 4
Interaction of atorvastatin with the human glial transporter SLC16A1
Sasaki, S., Futagi, Y., Ideno, M., Kobayashi, M., Narumi, K., Furugen, A., & Iseki, K. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.06.033 · Cited by 6
Assessment of bee venom therapy in animal model of statin-induced myopathy
Kader, A. A., Azmy, R. M., Maher, E. A., Sayed, B. B. E., Khalil, A. S., Ghalwash, M., & Mahmoud, M. M. (2019) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-019-0120-9 · Cited by 4
Busanello, E. N. B., Marques, A. C. S., Lorza‐Gil, E., Oliveira, H. C. F., & Vercesi, A. E. (2018) · InTech eBooks · doi:10.5772/intechopen.71610 · Cited by 3
Statins Stimulate Hepatic Glucose Production via the miR-183/96/182 ClusterPreprint
Marquart, T. J., Allen, R. M., Chen, M. R., Dorn, G. W., Matkovich, S. J., & Baldán, Á. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/726695 · Cited by 3
Al-Shalchi, R. F., & MOHAMMAD, F. K. (2024) · Applied In Vitro Toxicology · doi:10.1089/aivt.2024.0032 · Cited by 2
Chronic Hepatitis B: A Critical Discussion
Long, J., Wang, M., Chen, B., Zhang, J., & Wang, B. (2017) · Future Virology · doi:10.2217/fvl-2016-0094 · Cited by 2
Salehinezhad, F., Eshraghi, H., Kadivar, A., Shirian, S., Asghari, A., Aali, E., & Davoodian, N. (2019) · Kafkas Universitesi Veteriner Fakultesi Dergisi · doi:10.9775/kvfd.2019.21726 · Cited by 1
The effect of simvastatin induced neurotoxicity on mitochondrial function in human neuronal cells
Millichap, L. E., Turton, N., Alomosh, R., Heaton, R. A., Bateman, A., Al‐Shanti, N., Lightfoot, A. P., Damiani, E., Marcheggiani, F., Orlando, P., et al. (2025) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2025.2471807 · Cited by 1
Sjúrðarson, T., Larsen, S., Jensen, S. B. K., Bejder, J., Rasmussen, J., Borg, S. Á., Kristiansen, J., Meinhardsson, J. M., Olsen, H. W., Ellingsgaard, H., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-101425 · Cited by 1
Importance of Plasma Membrane Nanodomains in Skeletal Muscle Regeneration
Pająk, B., & Orzechowski, A. (2015) · InTech eBooks · doi:10.5772/60615
The Impact of Physical Activity on Statin-Associated Skeletal Muscle Myopathy
Chung, H. R., Wu, P.-T., Fitschen, P. J., Kistler, B. M., Park, H. W., Jeong, J. H., Wilund, K. R., Woods, J., & Boppart, M. D. (2015) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000477291.98365.c0
impair regenerative capacity in aging humans Heightened muscle inflammation susceptibility may
Kim, J., Bamman, M. M., Cross, J. M., Shelley, D., Tuggle, S. C., Kosek, D. J., Merritt, E. K., Stec, M. J., Thalacker‐Mercer, A. E., Williams, J. Y., et al. (2015)
Self-citationRegulation of legumain in human cells
Smith, R. L. (2014) · NORA - Norwegian Open Research Archives
Er cysteinproteaser involvert i statinindusert myotoksisitet
Voreland, A. L. (2013) · NORA - Norwegian Open Research Archives
Metadata
- Authors
- Kwak, H.-B., Thalacker-Mercer, A., Anderson, E. J., Lin, C.-T., Kane, D. A., Lee, N.-S., Cortright, R. N., Bamman, M. M., & Neufer, P. D.
- Affiliations
- East Carolina University (US)
- University of Alabama at Birmingham (US)
- Corresponding author
- Neufer, P. Darrell
- Venue
- Free Radical Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 52
- Issue
- 1
- Pages
- 198-207
- ISSN
- 0891-5849 (ISSN-L)
- PMC
- PMC3313473
- OpenAlex
- W1985595789
- Cited by
- 114
- References
- 52
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 7 · 2023: 4 · 2022: 4 · 2021: 2 · 2020: 6 · 2019: 13 · 2018: 10 · 2017: 10 · 2016: 11 · 2015: 11 · 2014: 12 · 2013: 12 · 2012: 7
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Free Radical Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01AG017896)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK073488, R01DK075880, R01DK074825)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Keywords
- simvastatin, statin-induced myopathy, skeletal muscle, myotubes, mitochondrial respiration, complex I, mitochondrial oxidative stress, superoxide, hydrogen peroxide, apoptosis, Bax, Bcl-2, mitochondrial permeability transition, myotube atrophy, rhabdomyolysis
- MeSH terms
- Adenosine Diphosphate, Anticholesteremic Agents, Cell Differentiation, Dose-Response Relationship, Drug, Humans, Hydrogen Peroxide, Mitochondria, Muscular Diseases, Oxygen Consumption, Superoxides, Signal Transduction, Gene Expression, Apoptosis, Oxidative Stress, Muscle Fibers, Skeletal, Cell Respiration, Respiratory System Agents, Proto-Oncogene Proteins c-bcl-2, Simvastatin, Myoblasts, Electron Transport Complex I, Primary Cell Culture
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review